# Acral Speckled Lentiginous Nevus

**Authors:** Natalia Maverakis Ramirez, Zachary J Jaeger, Hadas Skupsky, Anne Marie McNeill, Antoanella Calame

PMC · DOI: 10.7759/cureus.98813 · Cureus · 2025-12-09

## TL;DR

This paper presents a rare case of a speckled lentiginous nevus on the sole of a young woman's foot, highlighting its unusual location and benign nature.

## Contribution

The paper reports a novel case of acral speckled lentiginous nevus and reviews its clinical and genetic implications.

## Key findings

- SLN on acral skin is extremely rare and was confirmed in this case through histopathology.
- The lesion was associated with a postzygotic HRAS genetic variant, linking it to RASopathy.
- Small SLN lesions have a low risk of malignancy and do not require prophylactic surgery.

## Abstract

Speckled lentiginous nevus (SLN), also referred to as nevus spilus, is a common benign melanocytic neoplasm typically occurring as a small, café-au-lait-colored “speckled” patch studded with numerous darkly pigmented macules or papules. Herein, we present a unique case of SLN arising on the sole of the right foot in a young woman, which was reported to be gradually enlarging since a pregnancy two years prior. The lesion was removed by shave biopsy, and histopathology confirmed the diagnosis and ruled out atypical features. While SLN is quite common, the occurrence on acral skin is extremely rare. SLN is considered a mosaic RASopathy due to its embryological development through a postzygotic activating HRAS genetic variant. Although small lesions usually remain isolated, underlying SLN syndrome should be considered in extensive cases with associated neurologic or musculoskeletal abnormalities. Secondary melanocytic neoplasms commonly arise within SLN, but overall, small lesions carry a low risk of malignant transformation, and prophylactic surgical treatment is not necessary. We briefly discuss SLN occurring in special sites and report this novel case with a review of the literature on SLN.

## Linked entities

- **Genes:** HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265]

## Full-text entities

- **Genes:** HRAS (HRas proto-oncogene, GTPase) [NCBI Gene 3265] {aka C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV}
- **Diseases:** neurologic or musculoskeletal abnormalities (MESH:D009139), benign melanocytic neoplasm (MESH:D009369), SLN (MESH:D007911), nevus spilus (MESH:C536819)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12782291/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12782291/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12782291/full.md

---
Source: https://tomesphere.com/paper/PMC12782291